Your browser doesn't support javascript.
loading
Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel.
Ide, Yasushi; Otsuka, Taiga; Shimokawa, Mototsugu; Koga, Futa; Ueda, Yujiro; Nakazawa, Junichi; Komori, Azusa; Otsu, Satoshi; Arima, Shiho; Fukahori, Masaru; Makiyama, Akitaka; Shinohara, Yudai; Ueno, Shohei; Taguchi, Hiroki; Honda, Takuya; Shibuki, Taro; Nio, Kenta; Ureshino, Norio; Mizuta, Toshihiko; Mitsugi, Kenji; Shirakawa, Tsuyoshi.
Afiliação
  • Ide Y; Department of Internal Medicine, Karatsu Red Cross Hospital, Saga, Japan.
  • Otsuka T; Department of Internal Medicine, National Hospital Organization Saga Hospital, Saga, Japan.
  • Shimokawa M; Department of Medical Oncology, Saga Medical Center Koseikan, Saga, Japan; otsuka-t@umin.ac.jp.
  • Koga F; Department of Internal Medicine, Minato Medical Clinic, Fukuoka, Japan.
  • Ueda Y; Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan.
  • Nakazawa J; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
  • Komori A; Department of Hepatobiliary and Pancreatology, Saga Medical Center Koseikan, Saga, Japan.
  • Otsu S; Department of Hematology and Oncology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
  • Arima S; Department of Medical Oncology, Kagoshima City Hospital, Kagoshima, Japan.
  • Fukahori M; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan.
  • Makiyama A; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan.
  • Shinohara Y; Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Ueno S; Department of Internal Medicine, Division of Gastroenterology, Kurume University Hospital, Fukuoka, Japan.
  • Taguchi H; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.
  • Honda T; Cancer Center, Gifu University Hospital, Gifu, Japan.
  • Shibuki T; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.
  • Nio K; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.
  • Ureshino N; Department of Gastroenterology, Saiseikai Sendai Hospital, Kagoshima, Japan.
  • Mizuta T; Department of Gastroenterology, Imamura General Hospital, Kagoshima, Japan.
  • Mitsugi K; Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Shirakawa T; Department of Internal Medicine, Imari Arita Kyoritsu Hospital, Saga, Japan.
Anticancer Res ; 43(4): 1817-1826, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36974805
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão